ArticleClinical rheumatology2026
Low-to-moderate dose glucocorticoids in primary Sjögren's syndrome patients on hydroxychloroquine/iguratimod therapy: a target trial emulation study.
Xiangpeng Wang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.